UCSF's Dr. Craig Nelson weighs in on new depression treatment approved by FDA

SAN FRANCISCO (KGO) -- The FDA has approved a nasal spray to treat specific types of depression. It is the first new treatment approved for depression patients in decades.

RELATED: FDA allows treatment of depression with club drug's cousin

The nasal spray is derived from a party drug known as Ketamine or Special K.

Top Stories

Anthropic's IPO expected to reshape SF's housing market: 'Most of us can't afford houses'

• 28 minutes ago

Oakland family seeks justice after dog attack that killed beloved pet: 'She was taken from us'

WNBA Finals: Atlanta gets home matinee for Game 6 against Valkyries as NBA keeps primetime slot

• 2 hours ago

Watch the video above for an interview with Dr. Craig Nelson from UCSF on the use of Ketamine to treat depression.